Multimedia :: Tonix Pharmaceuticals Holding Corp. (TNXP)

Mar 25, 2022

Tonix Pharmaceuticals CEO talks through 2021 highlights, ending year with $179M in cash

Feb 11, 2022

Tonix Pharmaceuticals, Inc.’s (NASDAQ: TNXP) interview, Mr. Seth Lederman, CEO

Dec 11, 2021

Tonix Pharmaceuticals, Inc.’s (NASDAQ: TNXP) interview, Mr. Seth Lederman, CEO

Nov 17, 2021

Tonix begins work at its Infectious Disease R&D Center in Maryland, discusses RELIEF results

Oct 5, 2021

Tonix Pharmaceuticals, Inc.’s (NASDAQ:TNXP) interview with Mr. Seth Lederman, CEO

Aug 23, 2021

Tonix Pharma CEO discusses Phase 3 RALLY study results and intent to acquire new R&D facility

Aug 6, 2021

Tonix Pharmaceuticals CEO Seth Lederman returns to New to the Street

Jul 15, 2021

Tonix Pharmaceuticals to develop therapeutic to treat Long COVID Syndrome

Jun 25, 2021

Bitterroot leaders welcome Tonix Pharmaceuticals, see bioscience potential

Jun 23, 2021

Tonix Pharmaceuticals CEO, Seth Lederman, talks about their Company’s pharmaceutical products